Skip navigation
Real-Time Benefit Check & ePrior Authorization
Analytical Procedures & Methods Validation Europe

PC16205

This compendium consists of materials submitted by the speakers that complement their presentations. We understand what an important resource this material is and we have made a concerted effort to secure biographical sketches, outlines and related materials.

Additionally, you will find included helpful information on solution providers, publications and associations, including links to their websites.

Thank you for your patronage.

Presentations

The Evolving Medicaid Landscape and Contracting Implications

Joe deSimone
Research Director
Health Strategies Group

Potential Disruptions in Pricing

Kevin V. O’Leary
Vice President, Strategic Pricing and Reimbursement
Bayer HealthCare Pharmaceuticals Inc.

Innovative Contracting Approaches

Christian Scognamillo
Senior Corporate Counsel
Genentech

Unleashing Value — Outcome Based Contracting, Challenges and Opportunities

Shailja Dixit
Chief Medical Officer
Scientific Commercialization

Breakdown 340B Guidance

Erin Estey Hertzog, JD, MPH
Director, Health Law and Policy
Biotechnology Innovation Organization

A Commercial Pricing and Contracting 101

I. Breakdown Contract Structure and Strategy

II. Best Approaches to Contracting

III. How to Communicate Value to Commercial Payers

IV. Operationalize a Program/Process

V. How to Measure Success in Contracting

VI. Analysis of a Successful Negotiation

Althea Danzey
Director, Contracting
Eisai Inc.

Tina Mumford-Still
Senior Manager, Contracting
Eisai Inc.

B Innovative Solutions in Pricing and Contracting for Specialty Products

I. Overview of Risk-Share Agreements

II. Market Trends and Risk-Sharing — What Stakeholders are Taking on More Risk?

III. Why Might a Payer or Manufacturer be Interested in Risk-Share Agreements?

IV. Key Factors for Successful Agreements

V. Challenges Affecting Innovative Contracting Structures

VI. Legal Restrictions Effecting Implementation

VII. What Will be the Real World Impact of Risk-Share Agreements?

Jennifer M. Hinkel
Partner
McGivney Global Advisors

Tying it All Together — Key Takeaways from Workshops

Discussion Leaders:

Jennifer M. Hinkel
Partner
McGivney Global Advisors

Althea Danzey
Director, Contracting
Eisai Inc.

Tina Mumford-Still
Senior Manager, Contracting
Eisai Inc.

INTERACTIVE DISCUSSION
Assess the Correlation Between Commercial Contracting Strategies and Government Programs

Jennifer English
Director, Contracts and Pricing
Acorda Therapeutics, Inc.

Navigate the Complexities of Payer Mergers

Everett Crosland
Senior Director, Reimbursement Strategy
Sunovion Pharmaceuticals, Inc.

IDN PERSPECTIVE
Explore Best Practices to Contract with IDNs

Sean Poellnitz
Director, Contracting and Resource Utilization
Christus Health

Veronica T. Gibbons
Clinical Analyst, Contracting and Resource Utilization
Christus Health

Pharmaceutical Mergers and Acquisitions as it Relates to Product Costs —
Mitigate Pricing Risks

John Phillips
Advisory Director
Deloitte & Touche LLP

CASE STUDY
Coverage of Rare Disease Therapies in Medicaid and Medicare and the Impact on Patient Care

Jay Greissing
Director, U.S. Government Relations and Public Policy
Shire

Speaker Bios

Everett Crosland
Senior Director, Reimbursement Strategy
Sunovion Pharmaceuticals, Inc.

Althea Danzey
Director, Contracting
Eisai Inc.

Joe deSimone
Research Director
Health Strategies Group

Shailja Dixit
Chief Medical Officer
Scientific Commercialization

Jennifer English
Director, Contracts and Pricing
Acorda Therapeutics, Inc.

Veronica T. Gibbons
Clinical Analyst, Contracting and Resource Utilization
Christus Health

Jay Greissing
Director, U.S. Government Relations and Public Policy
Shire

Erin Estey Hertzog, JD, MPH
Director, Health Law and Policy
Biotechnology Innovation Organization

Jennifer M. Hinkel
Partner
McGivney Global Advisors

Tina Mumford-Still
Senior Manager, Contracting
Eisai Inc.

Kevin V. O’Leary
Vice President, Strategic Pricing and Reimbursement
Bayer HealthCare Pharmaceuticals Inc.

John Phillips
Advisory Director
Deloitte & Touche LLP

Sean Poellnitz
Director, Contracting and Resource Utilization
Christus Health

Christian Scognamillo
Senior Corporate Counsel
Genentech

  Agenda
Click here to view

SPONSORS

RxCrossroads CIS by Deloitte

Upcoming Events:

Expanded Access Programs 2016
February 23-24, 2016 • Washington, DC

Hub and SPP Model Optimization
February 23-24, 2016 • Philadelphia, PA

Bio/Pharmaceutical Pricing and Contracting
March 15-16, 2016 • Washington, DC

Medical Device Reimbursement & Access Summit
March 16-17, 2016 • Chicago, IL

2nd Annual Alternative Payment Models in Healthcare
March 17-18, 2016 • Orlando, FL

9th Annual Oncology Commercialization & Market Access
March 22-23, 2016 • San Francisco, CA

PBM Formulary Exclusions Summit
March 30-31, 2016 • Las Vegas, NV

Rx to OTC Switch
April 20-21, 2016 • Princeton, NJ

Reimbursement and Access 2016
August 17-18, 2016 • Philadelphia, PA

Coupon and Co-Pay Offset Strategies
September 13-14, 2016 • Philadelphia, PA

7th Hub and SPP Model Optimization
September 28-29, 2016 • San Diego, CA